Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes.

Fan W, Imamura T, Sonoda N, Sears DD, Patsouris D, Kim JJ, Olefsky JM.

J Biol Chem. 2009 May 1;284(18):12188-97. doi: 10.1074/jbc.M808915200. Epub 2009 Feb 26.

2.

Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells.

Dixit M, Bess E, Fisslthaler B, Härtel FV, Noll T, Busse R, Fleming I.

Cardiovasc Res. 2008 Jan;77(1):160-8. Epub 2007 Sep 19.

3.

Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle.

Beaulieu LM, Whitley BR, Wiesner TF, Rehault SM, Palmieri D, Elkahloun AG, Church FC.

Bioessays. 2007 Oct;29(10):1029-38. Review.

4.

The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.

Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A.

J Biol Chem. 2007 Oct 12;282(41):30107-19. Epub 2007 Aug 20.

6.

Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver.

Nakamura K, Moore R, Negishi M, Sueyoshi T.

J Biol Chem. 2007 Mar 30;282(13):9768-76. Epub 2007 Jan 30.

7.

A stress response pathway involving sirtuins, forkheads and 14-3-3 proteins.

Berdichevsky A, Guarente L.

Cell Cycle. 2006 Nov;5(22):2588-91. Epub 2006 Nov 15. Review.

PMID:
17172829
8.

Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.

Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y, Fukamizu A.

Cell Signal. 2007 Mar;19(3):519-27. Epub 2006 Aug 30.

PMID:
17113751
9.

CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.

Huang H, Regan KM, Lou Z, Chen J, Tindall DJ.

Science. 2006 Oct 13;314(5797):294-7.

10.

The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development.

Seo S, Fujita H, Nakano A, Kang M, Duarte A, Kume T.

Dev Biol. 2006 Jun 15;294(2):458-70. Epub 2006 Apr 3.

11.

Role of IkappaB kinase in tumorigenesis.

Hu MC, Hung MC.

Future Oncol. 2005 Feb;1(1):67-78. Review.

PMID:
16555977
12.

Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression.

Fujita H, Kang M, Eren M, Gleaves LA, Vaughan DE, Kume T.

Circ Res. 2006 Mar 17;98(5):626-34. Epub 2006 Feb 2.

13.

Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M.

Nature. 2004 Dec 23;432(7020):1027-32.

PMID:
15616563
14.

The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia.

Carlsson E, Almgren P, Hoffstedt J, Groop L, Ridderstråle M.

Obes Res. 2004 Nov;12(11):1738-43.

15.

Role of the FOXC2 -512C>T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome.

Carlsson E, Groop L, Ridderstråle M.

Int J Obes (Lond). 2005 Mar;29(3):268-74.

PMID:
15597109
16.

Expression and intracellular localization of FKHRL1 in mammary gland neoplasms.

Jin GS, Kondo E, Miyake T, Shibata M, Takashima T, Liu YX, Hayashi K, Akagi T, Yoshino T.

Acta Med Okayama. 2004 Aug;58(4):197-205.

17.

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, Dong HH.

J Clin Invest. 2004 Nov;114(10):1493-503.

18.

A novel frameshift mutation of FOXC2 gene in a family with hereditary lymphedema-distichiasis syndrome associated with renal disease and diabetes mellitus.

Yildirim-Toruner C, Subramanian K, El Manjra L, Chen E, Goldstein S, Vitale E.

Am J Med Genet A. 2004 Dec 15;131(3):281-6.

PMID:
15523639
19.

Foxa2 regulates multiple pathways of insulin secretion.

Lantz KA, Vatamaniuk MZ, Brestelli JE, Friedman JR, Matschinsky FM, Kaestner KH.

J Clin Invest. 2004 Aug;114(4):512-20.

20.

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control.

Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O.

J Biol Chem. 2004 Sep 24;279(39):41114-23. Epub 2004 Jul 21.

Items per page

Supplemental Content

Write to the Help Desk